Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Metixene hydrochloride hydrate has potential anticholinergic activity and inhibits the binding of quinine ring benzoate (QNB) to muscarine receptors, with IC50 and Ki values of 55 nM and 15 nM, respectively. Metixene hydrochloride hydrate can be used to prevent and treat Parkinson's disease.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 8,000 | |||
10 mg | 在庫あり | ¥ 13,000 | |||
25 mg | 在庫あり | ¥ 26,000 | |||
50 mg | 在庫あり | ¥ 41,000 | |||
100 mg | 在庫あり | ¥ 66,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 14,000 |
ターゲット&IC50 | mAChR:55 nM, mAChR:15 nM (Ki) |
分子量 | 363.95 |
分子式 | C20H26ClNOS |
CAS No. | 7081-40-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 5 mg/mL (13.74c), Sonication is recommended.
DMSO: 70 mg/mL (192.34 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Metixene hydrochloride hydrate 7081-40-5 Neuroscience AChR Metixene hydrochloride Hydrate Inhibitor inhibitor inhibit